William Blair analyst Andrew Brackmann has reiterated their neutral stance on QGEN stock, giving a Hold rating on November 5.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Andrew Brackmann has given his Hold rating due to a combination of factors impacting Qiagen’s outlook. Despite the company’s strong performance in the third quarter and successful execution of objectives within its control, external challenges such as market crosswinds and the government shutdown are influencing the company’s ability to achieve its revenue growth targets.
Additionally, with Qiagen’s shares trading at 17 times the projected earnings for 2026, the current valuation seems to already account for these uncertainties. Until there is more clarity and confidence in the company’s ability to accelerate its growth, maintaining a Hold rating appears prudent.
Based on the recent corporate insider activity of 14 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of QGEN in relation to earlier this year.